Pharmacovigilance as a tool for safety and monitoring: a review of general issues and the specific challenges with end-stage renal failure patients

Pharmacovigilance is instrumental in helping to ensure patient safety for both newly released drugs and those that are well established in the market. However, while pharmacovigilance procedures are strictly regulated in the clinical trial setting, post-marketing adverse event reporting is not well...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Dalia, Marrón, Belén, Ehrlich, Jay, Rutherford, Peter A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636760/
https://www.ncbi.nlm.nih.gov/pubmed/23637559
http://dx.doi.org/10.2147/DHPS.S43104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636760/
https://www.ncbi.nlm.nih.gov/pubmed/23637559
http://dx.doi.org/10.2147/DHPS.S43104

Ejemplares similares